TrialSpark IPO

trialspark.com

TrialSpark is a technology company focused on accelerating the pace of clinical trials to bridge the gap between medical research and patients who need treatment.

Founded2013
Total Funding to Date$246.91MM
Register for Details

For more details on financing and valuation for TrialSpark, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

TrialSpark Ticker Symbol

TrialSpark does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

TrialSpark Stock Price

The stock price for TrialSpark will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

TrialSpark Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/6/2021 Series C $1.04B $XXX.XX $XXX.XX
10/15/2018 Series B $377.41MM $XXX.XX $XXX.XX
9/28/2017 Series A $65.83MM $XXX.XX $XXX.XX
6/30/2016 Series Seed $9MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like TrialSpark in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM